McKinsey to Pay at Least $500 Million in DOJ Opioid Probe
- Settlement would resolve criminal and civil federal inquiries
- McKinsey has denied wrongdoing, said its past work was legal
This article is for subscribers only.
McKinsey & Co. is nearing a deal with US prosecutors to pay at least $500 million to settle federal probes into its past work helping opioid makers boost sales, according to people familiar with the matter.
A settlement, which could be announced in the coming weeks, would resolve criminal and civil investigations by the Justice Department, said the people, who asked not to be identified discussing a confidential matter. The terms haven’t been finalized and could still change.